<?xml version="1.0" encoding="UTF-8"?>
<p>There are several AD profiles, which include deficits in episodic memory, language, semantic knowledge, visuospatial abilities, executive functions in terms of planning and organisation as well as apraxia [
 <xref rid="B32-molecules-26-01107" ref-type="bibr">32</xref>]. Apart from neuronal loss, amyloid plaques and neurofibrillary tangles are inter-related to the presence of reactive astrocytes and activated microglial cells [
 <xref rid="B33-molecules-26-01107" ref-type="bibr">33</xref>,
 <xref rid="B34-molecules-26-01107" ref-type="bibr">34</xref>,
 <xref rid="B35-molecules-26-01107" ref-type="bibr">35</xref>]. Aβ is the most widely studied component of AD pathogenesis, where it can induce neuronal toxicity and activate microglia leading to the indirect damage of neurons [
 <xref rid="B36-molecules-26-01107" ref-type="bibr">36</xref>]. Proteolytic cleavage from the type I cell-surface protein amyloid precursor protein (APP) was known to yield several forms of Aβ [
 <xref rid="B37-molecules-26-01107" ref-type="bibr">37</xref>,
 <xref rid="B38-molecules-26-01107" ref-type="bibr">38</xref>]. The pathogenic hypotheses for synaptic and neuronal toxicity in Alzheimer’s disease is shown in 
 <xref ref-type="fig" rid="molecules-26-01107-f001">Figure 1</xref>.
</p>
